Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowe

Showing results (521-530 of 632) with videos related to

Pageof 64
Sort By:
EJNMMI Research|October 4, 2017
Correlation of <sup>99m</sup>Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expressionSteven P Rowe, Michael A Gorin, Lilja B Solnes, et al.
Scientific Reports|May 16, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinomaAndrew F Voter, Alireza Amindarolzarbi, Colette J Shen, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
PET Clinics|January 10, 2024
PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract CancersJorge D Oldan, Jennifer A Schroeder, Jean Hoffman-Censits, et al.
Radiology|July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate CancerAndrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
Radiology|July 19, 2022
<sup>18</sup>F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic ConfirmationGary A Ulaner, Beth Thomsen, Jeffrey Bassett, et al.
European Urology Focus|March 3, 2020
Cost-effectiveness Analysis of <sup>99m</sup>Tc-sestamibi SPECT/CT to Guide Management of Small Renal MassesZhuo T Su, Hiten D Patel, Mitchell M Huang, et al.
The Prostate|May 11, 2023
Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapyXinxing Du, Yanhao Dong, Jiazhou Liu, et al.
European Urology|September 21, 2015
Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe TumorsMichael A Gorin, Steven P Rowe, Alexander S Baras, et al.
Clinical Nuclear Medicine|March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and TherapyPhilipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
Pageof 64

Showing results (521-530 of 632) with videos related to

Sort By:
Pageof 64
EJNMMI Research|October 4, 2017
Correlation of <sup>99m</sup>Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expressionSteven P Rowe, Michael A Gorin, Lilja B Solnes, et al.
Scientific Reports|May 16, 2025
A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinomaAndrew F Voter, Alireza Amindarolzarbi, Colette J Shen, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
PET Clinics|January 10, 2024
PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract CancersJorge D Oldan, Jennifer A Schroeder, Jean Hoffman-Censits, et al.
Radiology|July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate CancerAndrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
Radiology|July 19, 2022
<sup>18</sup>F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic ConfirmationGary A Ulaner, Beth Thomsen, Jeffrey Bassett, et al.
European Urology Focus|March 3, 2020
Cost-effectiveness Analysis of <sup>99m</sup>Tc-sestamibi SPECT/CT to Guide Management of Small Renal MassesZhuo T Su, Hiten D Patel, Mitchell M Huang, et al.
The Prostate|May 11, 2023
Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapyXinxing Du, Yanhao Dong, Jiazhou Liu, et al.
European Urology|September 21, 2015
Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe TumorsMichael A Gorin, Steven P Rowe, Alexander S Baras, et al.
Clinical Nuclear Medicine|March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and TherapyPhilipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
Pageof 64